Christopher Price, Mba, Lean Six Sigma Greenbelt Certified Email and Phone Number
Have you ever considered investing in real estate but didn’t know where to start?I’m Chris Price, a partner at Boost Capital Group (BCG). We help busy professionals and entrepreneurs invest passively in commercial multifamily real estate. Before BCG, I co-founded Red Fox Multifamily, LLC to give busy pharmaceutical professionals access to vetted, cash-flowing real estate opportunities that are both recession-proof and offer above-average returns with minimal risk.With countless paths in real estate investing, which is the most rewarding?My journey might provide some insight.I’ve spent over 20 years as an executive in the corporate pharmaceutical industry, primarily managing business operations at Boehringer Ingelheim Pharmaceuticals, Inc., one of the world’s largest privately held pharmaceutical companies.While I’ve enjoyed my career, I knew early on that I wanted more—more time, security, and freedom. I began by investing in single-family rentals and soon transitioned to multifamily assets, discovering they offered lower risks and significantly higher rewards.Over the past decade, I’ve built a personal portfolio that includes over 1,266 multifamily units, totaling over $32.5 million in Assets Under Management (AUM) across strategic markets in the U.S. My goal in real estate investing is to build financial security and escape the volatility of the stock market.My passion for sharing this experience led me to organize The Wealth Mindset & Real Estate Investing Meetup in White Plains, NY, and to become active in the Bigger Pockets real estate community.These experiences, combined with an exceptional team of advisors, inspired me to found Red Fox Multifamily to help busy professionals, like myself, achieve financial security and generational wealth.When asked what I recommend to busy professionals looking to move away from Wall Street and into real estate, my answer is always the same: “Start passively investing in multifamily real estate.”Passive real estate investing allows you to diversify your portfolio with minimal risk. It offers lucrative, recession-resistant returns, tax savings, financial freedom, and a legacy asset—all without the headaches of being a landlord.Interested in learning more? Send me a message here.
Red Fox Multifamily, Llc
View- Website:
- redfoxmultifamily.com
- Employees:
- 1
-
Ceo And Co-FounderRed Fox Multifamily, LlcWhite Plains, Ny, Us
-
Managing MemberBoost Capital Group Feb 2024 - PresentOur mission is to help Business Leaders and Busy Professionals build passive streams of income by investing in private real estate opportunities. We have helped people invest in Private Real Estate Opportunities totaling over 4,000 apartments, $400M+ Portfolio Value, 20% Average Annual Return, 16% Average IRR, and 2.0x Equity Multiple (5-year annualized).Professionals often come to us when they’re looking for ways to preserve and grow their capital through passive real estate investments, as an alternative to the stock market.Our vision is that we believe that everyone deserves to spend time with their family while building a bright financial future. In order to do that, we offer alternative investment opportunities in real estate to busy professionals.Learn more about passive investing in private real estate opportunities at BoostMyCapital.com -
Ceo And Co-FounderRed Fox Multifamily, Llc Apr 2022 - PresentIn a single sentence: Busy professionals come to us for our in-depth knowledge of local markets and capital markets expertise to provide them curated recession-resistant opportunities in multifamily real estate opportunities. 5 Reasons why passive investing with Red Fox Multifamily might be right for you:✅ Earning lucrative returns by investing in recession-resistant multifamily real estate ✅ Receiving passive income and all the benefits of real estate WITHOUT the headaches of being a landlord✅ Experiencing financial freedom & build a lasting legacy for generations to come✅ Stressing Less every time the stock market takes a dip with low-risk investments✅ Diversifying your portfolio and learn why multifamily properties are the “cash cows” of real estate This recession-resistant real estate niche provides protection, predictable income, and peace of mind through any market cycle. With Red Fox Multifamily, busy professionals have the opportunity to earn lucrative returns at low risk, save on taxes, reach financial freedom and create a legacy asset that can be passed on.To find out more, visit www.redfoxmultifamily.com/webinar and register for our free training titled “How To Recession-Proof Your Retirement With Hands-Off Commercial Real Estate Investing”.
-
Director, Hp Review Committee And Go-To-Market Content LeadBoehringer Ingelheim Apr 2022 - PresentIngelheim Am Rhein, Rhineland-Palatinate, De> Lead all aspects of the U.S. Go-to-Market (GTM) Capability of content and agency management for therapeutic areas, including setting U.S. strategy.> Lead and inspire teams of employees and venders responsible for managing platforms and processes such as Digital Asset Management, Content Management, Agency Management, and Training Management for commercial, medicine, and 3rd party agencies and venders.> Lead U.S. GTM capabilities require of the marketing and medical functions (e.g. Non-Trial Activities, AE Reporting, Content Approval, Agency Training, Agency Financial Optimization) ensuring they meet business requirements, including developing roadmap development.> Foster TA relationships by offering proactive and innovative solutions, including gaining cross-functional alignment, and serve as the single point of contact and consultant/thought leader for commercial, medicine, compliance, legal, etc. -
Senior Associate Director, Marketing And Medical OperationsBoehringer Ingelheim Dec 2016 - May 2022Ingelheim Am Rhein, Rhineland-Palatinate, DeAs a corporate professional, I have taken on various roles of increasing responsibility across both medical affairs and commercial operations. Currently, Chris is Sr. Associate Director, Marketing & Medical Operations. In this role, Chris oversees all operational aspects of the Medical, Legal, and Regulatory (MLR) review process, as well as agency operations within the Respiratory & Established Brands area. Since, May, 2020, Chris has taken on all US Veeva Vault Program Management responsibilities.In my current position, I am responsible for all operational aspects for the review, approval, and production of all scientific/medical communications, non-promotional and promotional communications associated with the Respiratory (Spiriva® Respimat® (tiotropium bromide) Inhalation Spray, Stiolto® Respimat® (tiotropium bromide & olodaterol)), Established/Multi-Brands, and Cross-TA. This includes leadership and oversight of 4 direct reports responsible for managing the day-day aspects of the MLR and Agency-related processes.
-
Associate Director, Fbm Ops / Clinical Development & Medical Affairs (Cdma)Boehringer Ingelheim 2013 - Dec 2016Ingelheim Am Rhein, Rhineland-Palatinate, DeIn this position, I served as Secretary of the TAMRC Governance Council. This included oversight of the TAMRC processes and operations as well as coordinating the review and approval of scientific materials for use by MSLs and AMAs. I also directed all aspects of FBM technology operations management and business solutions as well as managing complex projects and overseeing general operations. Some of my most significant achievements in this role include:• Developed and implement tactics which enable multichannel approaches for FBM personnel to engage BIs scientific experts and key decision makers.• Executed US Medical Transformation Customer Identification and Prioritization program, which led to the achievement of ‘Veeva Hero’ award.• Directed the FBM Technology Subject Matter Expert team which influenced key FBM policies, procedures, technologies and business solutions.• Managed the development and implementation of the Veeva Vault Content Management System.• Led the development and implementation of Medical Review Committee SOPs and Guidelines.
-
Field Based Medicine Operations ManagerBoehringer Ingelheim 2012 - 2013Ingelheim Am Rhein, Rhineland-Palatinate, DeIn this role, I led the development of a business case for TAMRC OIP, securing management support and buy-in. I also oversaw development of the FBM Veeva CRM project, which laid the groundwork for subsequent implementation. Additionally, I developed our FBM technology vision, creating the framework for future implementation of programs to enhance and modernize systems.I was responsible for TAMRC teams (Cardiovascular (Pradaxa®), Metabolism (Linagliptin (Tradjenta®), Empagliflozin (Jardiance®)), and Virology (Faldaprevir), ensuring scientific materials were reviewed and approved timely and were appropriate for MSL use.
-
Specialist Iii, Fbm Ops / Operations And Business Development / CdmaBoehringer Ingelheim 2012 - 2012Ingelheim Am Rhein, Rhineland-Palatinate, DeI oversaw the Field Based Medicine Reengineering project, which reorganized the MSL function based on industry best practices and executing process improvements. I also led the TAMRC process documentation project and directed a project which identified the requirements, process mapping, and design of FBM US Next Generation CRM system.
-
Specialist Iii, Operations And Business Development / Medical Affairs OperationsBoehringer Ingelheim 2009 - 2012Ingelheim Am Rhein, Rhineland-Palatinate, DeI was responsible for overseeing the TAMRC for Cardiovascular, Metabolism and Virology, facilitating the review process and driving day-to-day operations. I also led the system and process improvement of the global Boehringer Ingelheim Opinion Leader Management Database CRM.I also collaborated on the Black Church Initiative pilot program, which piloted the delivery of quality health care information to the black population in an innovative way, using the church to do so.
-
Specialist Iii, Operations And Business Development / Health Sciences & SystemsBoehringer Ingelheim 2008 - 2009Ingelheim Am Rhein, Rhineland-Palatinate, DeI managed the development and implementation of the Boehringer Opinion Leader Management Database (BOLD) enhancement, completing the project on time and on budget. I also led a cross-functional team in the re-engineering of Strategic Opinion Leader Identification (SOLID) methodology. And I was elected Co–Chair of BIPIs African Heritage Business Resource Group (AHBR), Employee Resource Group (ERG).
-
Specialist Ii, Finance And Project Management / Health Sciences & SystemsBoehringer Ingelheim 2004 - 2008Ingelheim Am Rhein, Rhineland-Palatinate, DeIn this role, I directed the development and implementation of a Business Alignment Process (BAP) which aligned planning and spending ($130M) of Medical Affairs activities to the strategic objectives of marketed brands. Additionally, I worked closely with department heads to define and manage budgets and allocation of resources related to Medical Affairs.
-
Communications Coordinator, Health Sciences & Systems (Contracted Through Attache)Boehringer Ingelheim 2003 - 2004Ingelheim Am Rhein, Rhineland-Palatinate, DeI was responsible for executing and communicating specific guidance from HSS management to middle managers and the Field Base Medical Team efficiently and effectively. I coordinated and planned internal and external POA’s, team activities, conferences and meetings.
Christopher Price, Mba, Lean Six Sigma Greenbelt Certified Education Details
-
Boehringer Ingelheim Pharmaceuticals Inc. Continuous Process Improvement Training & EducationManagement And Operations -
Capella UniversityHealthcare Management
-
Villanova UniversityApplied Project Management
-
Marist CollegePublic Relations
Frequently Asked Questions about Christopher Price, Mba, Lean Six Sigma Greenbelt Certified
What company does Christopher Price, Mba, Lean Six Sigma Greenbelt Certified work for?
Christopher Price, Mba, Lean Six Sigma Greenbelt Certified works for Red Fox Multifamily, Llc
What is Christopher Price, Mba, Lean Six Sigma Greenbelt Certified's role at the current company?
Christopher Price, Mba, Lean Six Sigma Greenbelt Certified's current role is CEO and Co-Founder.
What schools did Christopher Price, Mba, Lean Six Sigma Greenbelt Certified attend?
Christopher Price, Mba, Lean Six Sigma Greenbelt Certified attended Boehringer Ingelheim Pharmaceuticals Inc. Continuous Process Improvement Training & Education, Capella University, Villanova University, Marist College.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial